Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending May 11, 2018. The document serves as a transaction notification reporting insider trading activities by Persons Discharging Managerial Responsibilities (PDMRs) and persons closely associated with them. The filing does not contain operational updates, earnings reports, or strategic business commentary.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It exclusively details specific share acquisition transactions.
| Transaction Date | Instrument | Price per Share | Total Volume | Exchange |
|---|---|---|---|---|
| May 10, 2018 | Ordinary Shares (25p each) | £14.6664 | 16 to 18 shares per executive | London Stock Exchange (XLON) |
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The document records routine acquisitions of ordinary shares under the Company's Share Reward Plan by nine senior executives. The transaction volumes are nominal, consisting of partnership shares and matching shares.
Guidance, Outlook, and Risks
The filing contains no management guidance, future outlook, risk factors, contingencies, or discussion of unusual items. It is a compliance notification regarding executive share ownership.
Key Facts for Investor Verification
- Transaction Nature: All reported transactions were acquisitions of ordinary shares under the Company's Share Reward Plan, not open market purchases or sales.
- Participants: Transactions involved nine senior executives, including the CEO (Ms E Walmsley), CFO (Mr S Dingemans), and Company Secretary (Mrs V A Whyte).
- Volume: Individual transaction volumes were minimal, ranging from 16 to 18 shares per executive.
- Price Consistency: All transactions occurred at a uniform price of £14.6664 per share on May 10, 2018.
- Scope Limitation: This filing does not contain financial performance data; investors should refer to Form 20-F or quarterly reports for financial metrics.